FDA Import Refusal 1FX-6032987-8/10002/1C — DAEHAN NEW PHARM
The FDA refused shipment 1FX-6032987-8/10002/1C from DAEHAN NEW PHARM (South Korea) on Oct 1, 2026. The refused product falls under Drugs and Biologics — SODIUM CHLORIDE (REPLENISHER). Cited charges: 118,3280,472,75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Oct 1, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 65RCK19 SODIUM CHLORIDE (REPLENISHER)
- Charges
- 118,3280,472,75